BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12456310)

  • 1. DNA methylation in brain development and gliomagenesis.
    Costello JF
    Front Biosci; 2003 Jan; 8():s175-84. PubMed ID: 12456310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in adult diffuse gliomas.
    LeBlanc VG; Marra MA
    Brief Funct Genomics; 2016 Nov; 15(6):491-500. PubMed ID: 27288434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.
    Wang H; Feng Y; Bao Z; Jiang C; Yan W; Wang Y; Zhang C; Liu Y; Zhang Q; Zhang W; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2089-96. PubMed ID: 24002581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular aspects of neuro-oncology.
    Santarius T; Kirsch M; Rossi ML; Black PM
    Clin Neurol Neurosurg; 1997 Aug; 99(3):184-95. PubMed ID: 9350399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
    Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene regulation by methylation.
    Mueller WC; von Deimling A
    Recent Results Cancer Res; 2009; 171():217-39. PubMed ID: 19322547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
    Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
    Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aberrant expression of sox2 gene in malignant gliomas].
    Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
    Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 promoter methylation in human gliomas.
    Amatya VJ; Naumann U; Weller M; Ohgaki H
    Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X; Wu F; Xu D; Zhang T
    J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the miR-126 gene associated with glioma progression.
    Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
    Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation matters.
    Costello JF; Plass C
    J Med Genet; 2001 May; 38(5):285-303. PubMed ID: 11333864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
    Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
    Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
    Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
    J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches.
    Riemenschneider MJ; Reifenberger G
    Curr Opin Neurol; 2009 Dec; 22(6):619-24. PubMed ID: 19741528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.